Surgepays Stock Investor Sentiment
| SURG Stock | USD 1.39 0.02 1.42% |
Roughly 76 percent of Surgepays' stockholders are selling. The analysis of overall sentiment of trading Surgepays stock suggests that a large number of investors are terrified at this time. The current market sentiment, together with Surgepays' historical and current headlines, can help investors time the market. In addition, many technical investors use Surgepays stock news signals to limit their universe of possible portfolio assets.
Surgepays |
Surgepays Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Surgepays can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Surgepays that are available to investors today. That information is available publicly through Surgepays media outlets and privately through word of mouth or via Surgepays internal channels. However, regardless of the origin, that massive amount of Surgepays data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Surgepays news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Surgepays relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Surgepays' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Surgepays alpha.
Surgepays Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | SurgePays director Richard Schurfeld buys 5,593 in stock | 11/20/2024 |
2 | SurgePays Establishes Strategic Agreement with ATT | 11/21/2024 |
3 | Acquisition by Weisberg Laurie of 301 shares of Surgepays at 1.83 subject to Rule 16b-3 | 11/25/2024 |
4 | Investors Appear Satisfied With SurgePays, Inc.s Prospects As Shares Rocket 25 | 11/29/2024 |
5 | Disposition of 36666 shares by Evers Anthony George of Surgepays at 1.86 subject to Rule 16b-3 | 12/02/2024 |
6 | SurgePays Expands Merchant Capabilities with LANDI Global Partnership | 12/03/2024 |
7 | SurgePays, Inc. CEO Kevin Brian Cox Sells 35,180 Shares | 12/05/2024 |
8 | Acquisition by Kevin Cox of 162054 shares of Surgepays at 0.124 subject to Rule 16b-3 | 12/20/2024 |
9 | GPOPlus Teams Up With SurgePays to Launch New Sales Channels | 01/15/2025 |
10 | Disposition of tradable shares by May David Allen of Surgepays subject to Rule 16b-3 | 01/17/2025 |
11 | Acquisition by Weisberg Laurie of 3099 shares of Surgepays at 1.8399 subject to Rule 16b-3 | 01/23/2025 |
12 | SurgePays Appoints Mark Garner as Executive Vice President | 01/24/2025 |
13 | Discretionary transaction by Schurfeld Richard Earl of tradable shares of Surgepays subject to Rule 16b-3 | 01/29/2025 |
14 | Synergetics.ai releases AgentWorks - a suite for Decentralized Autonomous AI Agents, and Agent-to-Agent Transactions | 02/05/2025 |
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |